Skip to content
Riskpilot
← Back to search
Sign in
Get full access
GE HEALTHCARE AS
AS
Active
Org 914829674
Nycoveien 1, 0485
Oslo
Manufacture of basic pharmaceutical products
· NACE 2110
Est. 1981
1161 employees
Watchlist
Share
Norway
/
Companies
/
Manufacture of basic pharmaceutical products
/
GE HEALTHCARE AS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (4)
KE
Karin Engelhardt Bourdeau
Deputy Member
Deputy Member
2025
HK
Henrik Kvikne Hansen
Deputy Member
Deputy Member
2023
CT
Cathrine Thomassen
Chief Executive Officer
Chief Executive Officer
2021
DS
Daniel Skurve
Deputy Member
Deputy Member
2025
Former (3)
RP
Roy Pedersen
Deputy Member
Deputy Member
2022 – 2023
HH
Helena Holte Stiland
Deputy Member
Deputy Member
2023 – 2025
AR
Aksel Reksten
Chief Executive Officer
Chief Executive Officer
2018 – 2021
Board of directors
Non-executive oversight
Name
Role
Member since
Current (8)
PA
Pål Arne Wøien
Board of Directors
2023
DR
Dina Rolfsvåg
Board of Directors
2025
KS
Kirsti Saga
Board of Directors
2023
JG
Jon Gabriel Noddeland
Board of Directors
2023
ES
Evy Stavik
Board of Directors
2023
KT
Kirsti Tollan Saga
Board of Directors
2025
HW
Herman Wilhelm Strand
Board of Directors
2025
NC
Niels Christian Aall
Chairman
2023
Former (7)
KS
Kristine Sillerud
Board of Directors
2023 – 2025
MD
Marianne Dahl
Board of Directors
2022 – 2023
EC
Eirik Christoffersen
Board of Directors
2021 – 2022
SE
Sara Emma Mari Lagerfelt
Board of Directors
2023 – 2023
GG
Georg Grøndalen
Board of Directors
2023 – 2025
AS
Atle Storaker
Board of Directors
2022 – 2023
AE
Aristoteles Eusebio Teixeira Nogueira Da Silva
Board of Directors
2024 – 2025
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Ge Healthcare Holding Norge As
Company
100%
100%
2024
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on GE HEALTHCARE AS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network